Marijuana industry taking fight against Wall Street blockades straight to Trump
Jan 9, 2026, 7:21 AM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
The lobbying efforts by Pot Inc. and potential regulatory changes could boost ACB's market position, similar to past instances where legislative changes positively affected cannabis stocks.
AI summary
What happened, with direct paths to the underlying reporting
Pot Inc. aims to lobby against Wall Street's restrictions on banking cannabis. Banks argue Trump's EO doesn't empower them to serve recreational cannabis businesses. Finalizing the EO rests on Attorney General Pam Bondi, who opposes legalization. Nasdaq permits Canadian pot companies due to U.S. regulatory barriers. Marc Cohodes asserts banks misinterpret Trump's order, potentially impacting industry growth.
Pot Inc. aims to lobby against Wall Street's restrictions on banking cannabis.
Banks argue Trump's EO doesn't empower them to serve recreational cannabis businesses.
Finalizing the EO rests on Attorney General Pam Bondi, who opposes legalization.
Nasdaq permits Canadian pot companies due to U.S. regulatory barriers.
Marc Cohodes asserts banks misinterpret Trump's order, potentially impacting industry growth.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Curaleaf's unsolicited $272 million bid for Aurora Cannabis, at a 45% premium and stock-plus-cash, could trigger strategic reassessment at ACB. The deal may boost margins and acce…
Aurora Cannabis reported the August 7, 2026 AGM results with 16,639,306 shares represented (26.86% of outstanding). Directors Martin, Singer, Kohli, Beauchamp and Uttamchandani dr…
Trump signed an order easing federal restrictions on marijuana. The order may enhance access to CBD treatment under Medicare. Key cannabis figures influenced the policy shift, res…